Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohnʼs disease - Wikidata - awgldk - TriplyDB

Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohnʼs disease

Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohnʼs disease

http://www.wikidata.org/entity/Q56638525

about

Herbal and plant therapy in patients with inflammatory bowel disease Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review Systematic review: the efficacy of herbal therapy in inflammatory bowel disease Potential role of nutraceutical compounds in inflammatory bowel disease Increased bioavailability of 11-keto-β-boswellic acid following single oral dose frankincense extract administration after a standardized meal in healthy male volunteers: modeling and simulation considerations for evaluating drug exposures.Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases.Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine model.Nutraceutical Supplements for Inflammatory Bowel Disease.A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease.Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence Induction of clinical response and remission of inflammatory bowel disease by use of herbal medicines: a meta-analysis Naringin ameliorates acetic acid induced colitis through modulation of endogenous oxido-nitrosative balance and DNA damage in rats.Phytochemicals and their potential usefulness in inflammatory bowel disease.Boswellic Acids and Their Role in Chronic Inflammatory Diseases.Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal.What gastroenterologists should know about the gray market, herbal remedies, and compounded pharmaceuticals and their regulation by the Food and Drug Administration.Drug-Herb Interactions in the Elderly Patient with IBD: a Growing Concern.Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases

P2860

Q26823835-CDBCFFCA-D628-48D8-B885-3A86324EFB5B Q26998841-84149DF8-33BB-4A35-950F-A3411A9F693D Q27004516-58726A39-F97A-4A13-9803-A6CE3D283C6A Q33572633-4FC100FB-507E-4C44-809F-0A6E92A71634 Q34240527-749740E1-3E78-4C76-BF3E-D62551230615 Q34419462-C5AA4668-7F76-4807-A3B0-32E240FAF3A2 Q34454367-9E6571FA-EB6D-4E0D-8C7F-3142255D3AF2 Q34511512-60DD4662-18C9-4876-B068-DAB4F2A8366D Q35646449-67B24932-2CDA-4525-BC24-8E3E0546716C Q35901531-E6234991-4729-4B84-A0DA-5A0341C3F564 Q37055823-16A038D2-0AA2-47BF-897E-E017E252A58E Q37162504-70471A7C-D57A-4641-86F0-B54BDF616FD2 Q37669820-4907954B-4FA3-4503-A086-BD42149E3270 Q38312093-2B98FA20-7124-4AD1-BA3B-141A62BADC58 Q38965222-BC3BA3C7-F388-4979-9473-40B320051C06 Q38970657-CA901F18-36CF-4F26-9FCA-F8A9C7A3E722 Q42756142-D89C0EE6-E153-4691-A269-C83270404C96 Q43971429-C5994992-FDDD-4712-BAA3-C4FD8839AAC2 Q50055464-4B85C2D6-7903-4669-BAFA-978BABEF3A67 Q57922384-04C59848-2258-4A80-915E-62F520C6856B

P2860

Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohnʼs disease

http://www.wikidata.org/entity/Q56638525

description

im Februar 2011 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 01 February 2011

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в лютому 2011

@uk

name

Randomized, placebo-controlled ...... g remission of Crohnʼs disease

@en

Randomized, placebo-controlled ...... g remission of Crohnʼs disease

@nl

type

label

Randomized, placebo-controlled ...... g remission of Crohnʼs disease

@en

Randomized, placebo-controlled ...... g remission of Crohnʼs disease

@nl

prefLabel

Randomized, placebo-controlled ...... g remission of Crohnʼs disease

@en

Randomized, placebo-controlled ...... g remission of Crohnʼs disease

@nl

P1433

Q56638525-4DBA1F41-A2FF-4BFB-A833-C223F6BA3B21

P1476

Q56638525-77E6FCFB-7AA3-4703-ACD7-0B95FF0EBBAE

P2093

Q56638525-1783BDC3-1E11-41A5-ABDC-714D618414A7

Q56638525-1B697689-3A5F-4B3E-8211-73B3BB46E194

Q56638525-28E18E1B-0952-4020-B618-8C0432808151

Q56638525-58B82FE6-E0A1-4EE4-81DD-B06C7B96CBC1

Q56638525-6693D4E1-C954-45D3-989E-28488CD2509D

Q56638525-8A0D1F8F-79A3-4F42-92FE-986D73C1A83D

Q56638525-AD578650-B1F8-445C-BBAF-8828F3119AEB

Q56638525-BB928458-42AF-4393-AB1B-43E51C3CEFB9

Q56638525-BC28B5D0-C341-46A4-8C5B-AFEC003C9093

Q56638525-EB2B928E-47FE-4BB1-92F6-F01DD009F547

P2860

Q56638525-16652673-BFCD-474C-AACC-7087D1C8B139

Q56638525-1E8907C7-B5D5-48D0-80FB-F524C1A3B3BF

Q56638525-28F53794-F676-4A62-962B-1DD5D5605E71

Q56638525-2AEFFCE4-EED7-4884-A36D-6DE1CA3CB7A9

Q56638525-4263ED27-EBE4-4B2D-ABFA-2B5CCBC90C3A

Q56638525-46751DE4-DE42-4B4F-ADB9-AEED76B813E8

Q56638525-498D49CD-F075-47B8-9F33-17097DE2F39B

Q56638525-6216C604-D6EF-423C-BDE9-8546048DBD7C

Q56638525-63BC551D-7D68-4F39-9561-C5302ABF4812

Q56638525-6EB8F296-8B16-4678-8692-7129606D374E

P304

Q56638525-37F00831-5112-4A2D-A256-AF1A628C618B

P31

Q56638525-FCB1465C-640D-4362-9920-2EAD248F7758

P356

Q56638525-C8C77DA0-8164-4FBC-8A37-9D77937B6A69

P433

Q56638525-9E5DBE0B-9C10-42C1-804F-6EF019FEFECE

P478

Q56638525-99FF09EA-4C2A-4FBB-B21C-9E99E57B0D4E

P50

Q56638525-961186F0-D4A0-404B-8642-FB5267C09535

P577

Q56638525-797E8F57-146B-4B76-AD51-508AE527724B

P5875

Q56638525-6BE3F436-BD1A-4A8E-9D39-006C2115F421

P698

Q56638525-AFF3C9B4-D009-4160-AFA8-3D51218E5F3D

P921

Q56638525-F969995C-3327-44FD-A346-7EC7FCD96DCA

P356

P1433

Inflammatory Bowel Diseases

P1476

Randomized, placebo-controlled ...... y profile but lack of efficacy

@en

P2093

Andreas Raedler

http://www.w3.org/2001/XMLSchema#string

Carsten Schmidt

http://www.w3.org/2001/XMLSchema#string

Christian Maaser

http://www.w3.org/2001/XMLSchema#string

Joachim Schwarz

http://www.w3.org/2001/XMLSchema#string

Jörg Schnitker

http://www.w3.org/2001/XMLSchema#string

Martin Zeitz

http://www.w3.org/2001/XMLSchema#string

Stefan Zeuzem

http://www.w3.org/2001/XMLSchema#string

Stephan Böhm

http://www.w3.org/2001/XMLSchema#string

Wolfgang Caspary

http://www.w3.org/2001/XMLSchema#string

Wolfgang Holtmeier

http://www.w3.org/2001/XMLSchema#string

P2860

Therapy of active Crohn disease with Boswellia serrata extract H 15

Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial

Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis

Effects of Boswellia serrata in mouse models of chemically induced colitis

Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease.

Frankincense: systematic review.

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.

The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review.

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

[Clinical practice guideline on diagnosis and treatment of Crohn's disease].

P304

573-582

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IBD.21345

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46289696

http://www.w3.org/2001/XMLSchema#string

P698

20848527

http://www.w3.org/2001/XMLSchema#string

P921